DaVita Inc. (NYSE:DVA) Shares Sold by CANADA LIFE ASSURANCE Co

CANADA LIFE ASSURANCE Co cut its stake in DaVita Inc. (NYSE:DVA - Free Report) by 21.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 80,010 shares of the company's stock after selling 21,623 shares during the period. CANADA LIFE ASSURANCE Co owned approximately 0.10% of DaVita worth $11,947,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. SBI Securities Co. Ltd. acquired a new stake in shares of DaVita in the 4th quarter worth $41,000. Canada Post Corp Registered Pension Plan acquired a new stake in DaVita during the fourth quarter worth about $55,000. Venturi Wealth Management LLC raised its stake in DaVita by 59.8% during the fourth quarter. Venturi Wealth Management LLC now owns 406 shares of the company's stock worth $61,000 after purchasing an additional 152 shares during the period. Versant Capital Management Inc boosted its holdings in DaVita by 58.7% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company's stock valued at $68,000 after purchasing an additional 169 shares during the last quarter. Finally, Blue Trust Inc. grew its stake in shares of DaVita by 39.7% in the 4th quarter. Blue Trust Inc. now owns 461 shares of the company's stock valued at $76,000 after buying an additional 131 shares during the period. Institutional investors and hedge funds own 90.12% of the company's stock.

DaVita Stock Up 0.5 %

DaVita stock traded up $0.71 during mid-day trading on Thursday, reaching $139.64. 648,254 shares of the company's stock were exchanged, compared to its average volume of 839,940. DaVita Inc. has a twelve month low of $130.96 and a twelve month high of $179.60. The company has a fifty day moving average of $146.81 and a 200-day moving average of $155.40. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18. The company has a market cap of $11.17 billion, a P/E ratio of 13.00, a P/E/G ratio of 1.07 and a beta of 1.04.

DaVita (NYSE:DVA - Get Free Report) last released its earnings results on Thursday, February 13th. The company reported $2.24 EPS for the quarter, topping the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. Sell-side analysts expect that DaVita Inc. will post 10.76 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research firms have commented on DVA. Barclays lifted their target price on DaVita from $164.00 to $169.00 and gave the company an "equal weight" rating in a research report on Tuesday, February 18th. StockNews.com raised shares of DaVita from a "hold" rating to a "buy" rating in a research note on Thursday, April 10th. Sanford C. Bernstein set a $184.00 price target on shares of DaVita in a research note on Friday, February 21st. Finally, Cowen reaffirmed a "hold" rating on shares of DaVita in a research report on Tuesday, February 18th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $166.33.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.